JP2023549300A5 - - Google Patents
Info
- Publication number
- JP2023549300A5 JP2023549300A5 JP2022555685A JP2022555685A JP2023549300A5 JP 2023549300 A5 JP2023549300 A5 JP 2023549300A5 JP 2022555685 A JP2022555685 A JP 2022555685A JP 2022555685 A JP2022555685 A JP 2022555685A JP 2023549300 A5 JP2023549300 A5 JP 2023549300A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- humanized antibody
- sequence shown
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011307482 | 2020-11-20 | ||
| CN202011307482.7 | 2020-11-20 | ||
| PCT/CN2021/131343 WO2022105814A1 (en) | 2020-11-20 | 2021-11-18 | Humanized anti-trka antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023549300A JP2023549300A (ja) | 2023-11-24 |
| JP2023549300A5 true JP2023549300A5 (https=) | 2024-10-28 |
| JP7837873B2 JP7837873B2 (ja) | 2026-03-31 |
Family
ID=81595256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555685A Active JP7837873B2 (ja) | 2020-11-20 | 2021-11-18 | ヒト化抗ＴｒｋＡ抗体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230357411A1 (https=) |
| EP (1) | EP4247852A4 (https=) |
| JP (1) | JP7837873B2 (https=) |
| CN (1) | CN114516917B (https=) |
| AU (1) | AU2021382828A1 (https=) |
| TW (1) | TWI880048B (https=) |
| WO (1) | WO2022105814A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120360963B (zh) * | 2025-04-23 | 2026-02-27 | 广州芬瑞生物科技有限公司 | 干细胞外泌体制备方法及该方法制备的外泌体在治疗男性勃起功能障碍中的用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6833268B1 (en) | 1999-06-10 | 2004-12-21 | Abgenix, Inc. | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| AU7311501A (en) * | 2000-06-29 | 2002-03-22 | Quick Med Technologies Inc | Cosmetic composition and method |
| ITRM20030601A1 (it) * | 2003-12-24 | 2005-06-25 | Lay Line Genomics Spa | Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti. |
| EP2252633B9 (en) * | 2008-02-04 | 2014-02-19 | Lay Line Genomics S.P.A. | Anti-trka antibodies and derivatives thereof |
| US9539324B2 (en) * | 2010-12-01 | 2017-01-10 | Alderbio Holdings, Llc | Methods of preventing inflammation and treating pain using anti-NGF compositions |
| US20150183885A1 (en) * | 2012-06-08 | 2015-07-02 | Glenmark Pharmaceuticals S.A. | Anti-trka antibodies with enhanced inhibitory properties and derivatives thereof |
| ES2666126T3 (es) | 2012-06-08 | 2018-05-03 | Glenmark Pharmaceuticals S.A. | Anticuerpos anti-TrkA humanizados con sustituciones de aminoácidos |
| EP2674439B1 (en) * | 2012-06-13 | 2017-02-01 | Rottapharm Biotech S.r.l. | Anti-TrkA antibodies, derivatives and uses thereof |
| US20170362327A1 (en) * | 2015-04-24 | 2017-12-21 | Glenmark Pharmaceuticals S.A. | Anti-trka antibodies with enhanced inhibitory properties and derivatives thereof for use in treating bone associated pain |
| WO2018166461A1 (en) | 2017-03-14 | 2018-09-20 | Sunshine Lake Pharma Co., Ltd. | Dual-target fusion proteins comprising the fc portion of an immunoglobulin |
| EP3976657A4 (en) * | 2019-05-30 | 2023-07-05 | Sunshine Lake Pharma Co., Ltd. | ANTI-TRKA ANTIBODIES AND USES THEREOF |
-
2021
- 2021-11-18 JP JP2022555685A patent/JP7837873B2/ja active Active
- 2021-11-18 EP EP21893961.9A patent/EP4247852A4/en active Pending
- 2021-11-18 WO PCT/CN2021/131343 patent/WO2022105814A1/en not_active Ceased
- 2021-11-18 CN CN202111365634.3A patent/CN114516917B/zh active Active
- 2021-11-18 AU AU2021382828A patent/AU2021382828A1/en active Pending
- 2021-11-18 US US17/911,571 patent/US20230357411A1/en active Pending
- 2021-11-19 TW TW110143134A patent/TWI880048B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12410256B2 (en) | Antibodies that specifically bind to TL1a and methods of treating gastrointestinal or lung diseases | |
| US11999783B2 (en) | Method of treating autoimmune disease with antibodies against IL-33 | |
| JP2022533855A5 (https=) | ||
| KR20220121850A (ko) | 항-cd73 항체 및 이의 용도 | |
| JP2021518140A5 (https=) | ||
| CN108026169A (zh) | 抗人cd137的完全人抗体及其应用 | |
| JP2006081548A5 (https=) | ||
| CN116761821B (zh) | 抗par-2抗体及其使用方法 | |
| CN110997722A (zh) | Cd38调节抗体 | |
| JP2023549300A5 (https=) | ||
| CN111032693A (zh) | Cd38调节抗体 | |
| US8926978B2 (en) | Antibodies directed against nerve growth factor (NGF) | |
| CN114516917B (zh) | 人源化抗TrkA的抗体及其应用 | |
| JP2024540196A (ja) | Ｃｃｒ２を標的とする抗体 | |
| CN116113434A (zh) | 对Fc γ RIIB具有选择性的异二聚体Fc变体 | |
| WO2024259273A2 (en) | Mhc class i chain-related protein a (mica)-specific antibodies and uses thereof | |
| WO2024108158A1 (en) | Anti-activin a/b antibodies and uses thereof | |
| HK40069212A (en) | Antibodies against il-1 beta |